Which types of medications are not commonly involved in severe medication errors?

Among the drug categories listed, central nervous system (CNS) medications as a broad class are not consistently identified as the most common contributors to severe, life-threatening medication errors in clinical settings. In contrast, anticoagulants (such as heparin and warfarin), diabetes medications (especially insulin), and chemotherapeutic agents are repeatedly identified by organizations such as the Institute for Safe Medication Practices (ISMP) as high-alert medications — drugs that bear a heightened risk of causing significant patient harm when used in error. Anticoagulants have a narrow therapeutic index and require careful monitoring; dosing errors can cause severe hemorrhage or thrombosis. Insulin errors can cause profound hypoglycemia or hyperglycemia. Chemotherapeutic agents have extremely narrow safety margins, and dosing errors can be fatal. While some CNS medications (such as opioids) do carry high-alert designations individually, the CNS category as a whole is not uniformly listed among the most commonly implicated classes in severe medication errors the way the other three categories are. Students should recognize that anticoagulants, insulin, and chemotherapy are cornerstone examples taught in medication-safety curricula because of their potential for catastrophic harm.